Among the most prominent theoretical frameworks dealing with the economic underlyings of firms' make-or-buy decisions are Transaction Cost Economics (TCE) and the Resourced Based View (RBV). Relying on panel data covering 107 European firms over eight years I test predictions from both TCE and...

There has been a wide-spread misconception based on the imprecise wording of Art. 52 of the European Patent Convention (EPC) that the protection of business methods by patents is prohibited in Europe. This paper investigates the legal framework set by patent laws with respect to the...

Eine gute Planung ist die Grundlage für Erfolg Höhere Erfolgschancen: Eine solide Businessplanung ist ein essenzieller Bestandteil vor, bei und nach der Gründung eines Unternehmens und minimiert die finanziellen Risiken. Schritt für Schritt stellt das Buch die relevanten Bereiche einer...

Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of the underlying invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent invalidation during drug development renders data...